DoGood Member Spotlight: Shola Oyewole
Professional Bio:
I have dedicated over 24 years to United Therapeutics Corporation (UT), playing a pivotal role in transforming it into a $13 billion biotech leader. Our groundbreaking work focuses on manufacturing an unlimited supply of transplantable organs by leveraging technologies such as 3D bio-printing, xeno-transplantation and regenerative sciences.
As a member of the Senior Executive Leadership at United Therapeutics Corporation (UT), I have an eye that looks at what others look at but can see industry trends and technology shifts that help UT disrupt the industry and lead her peers. My keen observations and insightful listenings, aid UT Senior Management in making strategic decisions.
I collaborate across Finance, HR, IT, R&D, Manufacturing, Sales & Marketing, and various business units to ideate solutions that enhance both distributed and centralized operations. My efforts streamline enterprise-wide processes, improving efficiency and cost-effectiveness. I facilitate seamless communication among the Board, senior management, UT staff, business partners, high-tech and pharmaceutical vendors, and external partners.
Core Responsibilities:
Serve as a subject matter expert on emerging technologies.
Develop processes to integrate emerging tech with innovative projects.
Propose solutions enhancing user experiences.
Network with universities, research organizations, startups, and Silicon Valley companies.
Promote continuous education on industry and global innovations.
Maintain constant stakeholder communication within the company and with business partners.
Provide internal grants for innovative ideas, fostering a culture of innovation through open innovation events.
I communicate clearly, execute swiftly, think creatively, and act with courage.
Company Name & Description:
United Therapeutics Corp.,
Company Website:
Year Founded:
1996
Headquarters Location:
Silver Spring , Maryland
Primary Area of Focus:
Manufacturing and distribution of drugs for a rare disease, Pulmonary Arterial Hypertension (PAH) and research & developing human organs through 3D bio printing and xeno (animal to human transplantable) organs.
LinkedIn Profile:
